BR112014005011A2 - composto, métodos de tratamento e composição farmacêutica - Google Patents

composto, métodos de tratamento e composição farmacêutica

Info

Publication number
BR112014005011A2
BR112014005011A2 BR112014005011A BR112014005011A BR112014005011A2 BR 112014005011 A2 BR112014005011 A2 BR 112014005011A2 BR 112014005011 A BR112014005011 A BR 112014005011A BR 112014005011 A BR112014005011 A BR 112014005011A BR 112014005011 A2 BR112014005011 A2 BR 112014005011A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
treatment methods
treatment
methods
Prior art date
Application number
BR112014005011A
Other languages
English (en)
Portuguese (pt)
Inventor
Haynes Nancy-Ellen
Robert Scott Nathan
John Silvester Huby Nicholas
Original Assignee
F Hoffamann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffamann-La Roche Ag filed Critical F Hoffamann-La Roche Ag
Publication of BR112014005011A2 publication Critical patent/BR112014005011A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR112014005011A 2011-09-01 2012-08-29 composto, métodos de tratamento e composição farmacêutica BR112014005011A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161529942P 2011-09-01 2011-09-01
PCT/EP2012/066721 WO2013030205A1 (en) 2011-09-01 2012-08-29 Parp inhibitors

Publications (1)

Publication Number Publication Date
BR112014005011A2 true BR112014005011A2 (pt) 2017-05-30

Family

ID=46796563

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014005011A BR112014005011A2 (pt) 2011-09-01 2012-08-29 composto, métodos de tratamento e composição farmacêutica

Country Status (9)

Country Link
EP (1) EP2758370A1 (ko)
JP (1) JP2014531416A (ko)
KR (1) KR20140062096A (ko)
CN (1) CN103906730A (ko)
BR (1) BR112014005011A2 (ko)
CA (1) CA2846429A1 (ko)
MX (1) MX2014002343A (ko)
RU (1) RU2014110624A (ko)
WO (1) WO2013030205A1 (ko)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5441864A (en) * 1977-09-02 1979-04-03 Sankyo Co Ltd Beta-lactam homolog and its preparation
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
JP2009539963A (ja) * 2006-06-15 2009-11-19 クドス ファーマシューティカルズ リミテッド Ｐａｒｐ阻害剤
WO2010139966A1 (en) * 2009-06-05 2010-12-09 Oslo University Hospital Hf Azole derivatives as wtn pathway inhibitors

Also Published As

Publication number Publication date
EP2758370A1 (en) 2014-07-30
CA2846429A1 (en) 2013-03-07
KR20140062096A (ko) 2014-05-22
MX2014002343A (es) 2014-04-30
RU2014110624A (ru) 2015-10-10
CN103906730A (zh) 2014-07-02
JP2014531416A (ja) 2014-11-27
WO2013030205A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
BR112015002738A2 (pt) composto , e , composição farmacêutica
BR112014002621A2 (pt) anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
DK2694038T3 (da) Farmaceutisk sammensætning
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112014023937A2 (pt) composição farmacêutica, agente farmacêutico de combinação e método de tratamento
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BR112013010725A2 (pt) método, e, composição
RS61827B1 (sr) Farmaceutska kompozicija, postupci za lečenje i njihova primena
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
BR112014004192A2 (pt) composição de tratamento de sementes, e, método de tratamento de sementes
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
BR112014007203A2 (pt) composto, composição farmacêutica, método de tratamento, utilização de um composto, conjunto e invenção
BR112013014644A2 (pt) composição farmacêutica e complexo
BR112014009889A2 (pt) compostos dissubstituídos, compostos e composição farmacêutica
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
BR112014009950A2 (pt) composto dissubstituído, compostos e composição farmacêutica
BR112013019327A2 (pt) composto, e, composição.
BR112013022820A2 (pt) método de tratamento
BR112013022306A2 (pt) método, e, composição
BR112014003556A2 (pt) método de tratamento de vírus, e, composição farmacêutica
CO6811865A2 (es) Método de tratamiento de la fiebre dengue
BR112014012759A2 (pt) composto, composição e método para tratamento
BR112013019224A2 (pt) composição, e metodo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired